Oncogenesis · 2017 · 73 citations · 15 references
MedicineMolecular BiologyOncologyGene ExpressionMetastasisSignal TransductionCancer Cell SignalingCancer ProgressionMetastatic Breast CancerMetastatic Signaling PathwaysOncogenic Signaling PathwaysSignal Transduction In CancerCancer Signaling PathwaysEpithelial-mesenchymal Transition MarkersMetastatic SignalingPro-tumorigenic SignalingProteoglycan SignalingProteoglycans In CancerTriple-negative Breast Cancer RecurrenceTumor Metastasis Biology
Patients with triple-negative breast cancers (TNBC) are at a high risk for a recurrent or metastatic disease, and the molecular mechanisms associated with this risk are unclear. Proteoglycan serglycin (SRGN) proteins are involved in tumor metastasis, but their role in TNBC has not yet been elucidated. This study investigates the SRGN gene expression and how it regulates TGFβ2 and the downstream signaling of TGFβ2 in TNBC cells and tissues. Our results show that SRGN mRNA and protein expression levels were significantly higher in TNBC cell lines and tumor tissues than that in non-TNBC cells and tissues. We inhibited SRGN expression and protein secretion using shRNA and we observed this inhibited the invasive motility of TNBC cancer cells in vitro and metastasis of TNBC cancer cells in vivo. SRGN protein treatment increased the expression and secretion of transforming growth factor-β2 (TGFβ2) by activating CD44/CREB1 signaling and promoted epithelial-to-mesenchymal transition in TNBC cells. Moreover, TGFβ2 treatment increased the mRNA and protein expression of the SRGN gene by activating Smad3 to target the SRGN relative promoter domain in TNBC cells. Our findings demonstrate that SRGN interacts with TGFβ2 which regulates TNBC metastasis via the autocrine and paracrine routes. SRGN could serve as a potential target for development of agents or therapeutics for the TNBC.
15
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Sendurai A. Mani, Wenjun Guo, Mai-Jing Liao et al. · Cell · 2008 · 8.7K citations · Full text
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour, Joan Font-Burgada, Giuseppe Di et al. · Nature · 2015 · 594 citations
Medicine, Immunology, Oncology +14
Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis
Xinjian Li, Choon Kiat Ong, Yun Cao et al. · Cancer Research · 2011 · 136 citations · Full text
Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma
Laura Rodón, Alba Gonzàlez-Juncà, María del Mar Inda et al. · Cancer Discovery · 2014 · 79 citations · Full text